On June 28th, STENTiT was awarded first prize in the TERMIS European Business Plan Competition.
After 2 intense pre-selection rounds, 5 out of 19 teams eventually made it to the finals and pitched in Davos, Switzerland. STENTiT was chosen as the winner of the competition due to the quality of the pitch, the technological approach and the high impact that regenerative stents can have on the society.
The TERMIS-EU Pre-Accelerator Programme and TERMIS-EU Business Plan Competition aim to inspire and equip innovative early career researchers in the fields of tissue engineering and regenerative medicine and accelerate the translation of their life-changing ideas from bench to market.
For more information see the official website.